Published in J Immunol on December 01, 1977
Structure and function of the visual arrestin oligomer. EMBO J (2007) 1.66
Characterization of IL-17+ interphotoreceptor retinoid-binding protein-specific T cells in experimental autoimmune uveitis. Invest Ophthalmol Vis Sci (2007) 1.49
Major role of gamma delta T cells in the generation of IL-17+ uveitogenic T cells. J Immunol (2009) 1.48
Role of oxygen free radicals in retinal damage associated with experimental uveitis. Trans Am Ophthalmol Soc (1990) 1.47
Isolation and structure of an arrestin gene from Drosophila. Proc Natl Acad Sci U S A (1990) 1.41
Cyclosporin a. Inhibition of experimental autoimmune uveitis in Lewis rats. J Clin Invest (1981) 1.40
A model for the solution structure of the rod arrestin tetramer. Structure (2008) 1.37
Primary and secondary structure of bovine retinal S antigen (48-kDa protein). Proc Natl Acad Sci U S A (1987) 1.25
The functional cycle of visual arrestins in photoreceptor cells. Prog Retin Eye Res (2011) 1.23
Overexpression of rhodopsin alters the structure and photoresponse of rod photoreceptors. Biophys J (2009) 1.18
Concentration-dependent tetramerization of bovine visual arrestin. Biophys J (2003) 1.15
Identification of an immunodominant and highly immunopathogenic determinant in the retinal interphotoreceptor retinoid-binding protein (IRBP). J Exp Med (1989) 1.12
A role for the light-dependent phosphorylation of visual arrestin. Proc Natl Acad Sci U S A (1999) 1.09
Regulation of rhodopsin kinase by autophosphorylation. Proc Natl Acad Sci U S A (1991) 1.07
Human retinal pigment epithelial cells differentially express MHC class II (HLA, DP, DR and DQ) antigens in response to in vitro stimulation with lymphokine or purified IFN-gamma. Clin Exp Immunol (1988) 1.06
Endogenous posterior uveitis. Br J Ophthalmol (1990) 1.06
Altered chemokine profile associated with exacerbated autoimmune pathology under conditions of genetic interferon-gamma deficiency. Invest Ophthalmol Vis Sci (2007) 1.06
Longitudinal study of serum antibody responses to bovine retinal S-antigen in endogenous granulomatous uveitis. Br J Ophthalmol (1983) 1.05
Silent scaffolds: inhibition OF c-Jun N-terminal kinase 3 activity in cell by dominant-negative arrestin-3 mutant. J Biol Chem (2012) 1.04
Structural determinants of arrestin functions. Prog Mol Biol Transl Sci (2013) 1.01
S-antigen immunoreactivity in human pineal glands and pineal parenchymal tumors. A monoclonal antibody study. Acta Neuropathol (1986) 1.01
Opposing effects of inositol hexakisphosphate on rod arrestin and arrestin2 self-association. Biochemistry (2007) 0.99
Autoimmune myocarditis induced in mice by cardiac C-protein. Cloning of complementary DNA encoding murine cardiac C-protein and partial characterization of the antigenic peptides. J Clin Invest (1994) 0.99
Visual Arrestin 1 contributes to cone photoreceptor survival and light adaptation. Invest Ophthalmol Vis Sci (2009) 0.99
A suppressive oligodeoxynucleotide inhibits ocular inflammation. Clin Exp Immunol (2009) 0.98
Robust self-association is a common feature of mammalian visual arrestin-1. Biochemistry (2011) 0.97
IL-22-induced regulatory CD11b+ APCs suppress experimental autoimmune uveitis. J Immunol (2011) 0.96
Experimental posterior uveitis. I: A clinical, angiographic, and pathological study. Br J Ophthalmol (1987) 0.96
Immunopathology of uveitis. Br J Ophthalmol (1998) 0.95
Beta-arrestin and arrestin are recognized by autoantibodies in sera from multiple sclerosis patients. Proc Natl Acad Sci U S A (1993) 0.95
GABAA and GABAC receptors in adult porcine cones: evidence from a photoreceptor-glia co-culture model. J Physiol (1998) 0.94
Effects of CD8 depletion on retinal soluble antigen induced experimental autoimmune uveoretinitis. Immunology (1993) 0.91
[Sympathetic ophthalmia]. Ophthalmologe (2009) 0.91
Morphometric analysis of T lymphocyte compartmentation in experimental autoimmune uveoretinitis. Clin Exp Immunol (1989) 0.90
Naturally occurring antibodies to bovine and human retinal S antigen: a comparison between uveitis patients and healthy volunteers. Br J Ophthalmol (1989) 0.89
Retinal S-antigen immunoreactivity in medulloblastomas. Acta Neuropathol (1988) 0.88
Lymphokine-induced MHC class II antigen expression on cultured retinal pigment epithelial cells and the influence of cyclosporin A. Immunology (1988) 0.88
An 18-mer peptide derived from the retinal S antigen induces uveitis and pinealitis in primates. Clin Exp Immunol (1989) 0.88
Structure and functions of arrestins. Protein Sci (1994) 0.88
Experimental autoimmune uveoretinitis (EAU) versus experimental allergic encephalomyelitis (EAE): a comparison of T cell-mediated mechanisms. Clin Exp Immunol (1992) 0.88
CRALBP is a highly prevalent autoantigen for human autoimmune uveitis. Clin Dev Immunol (2007) 0.86
Identification of a peptide inducing experimental autoimmune uveoretinitis (EAU) in H-2Ak-carrying mice. Clin Exp Immunol (1998) 0.85
Arrestin-3 binds c-Jun N-terminal kinase 1 (JNK1) and JNK2 and facilitates the activation of these ubiquitous JNK isoforms in cells via scaffolding. J Biol Chem (2013) 0.85
Enolase and arrestin are novel nonmyelin autoantigens in multiple sclerosis. J Clin Immunol (2007) 0.84
Bowman lecture on the role of inflammation in degenerative disease of the eye. Eye (Lond) (2013) 0.84
Oligoclonal activation of CD4+ T lymphocytes in posterior uveitis. Clin Exp Immunol (1995) 0.84
Experimental posterior uveitis. II. Electroretinographic studies. Br J Ophthalmol (1988) 0.82
Ocular immune privilege in the year 2010: ocular immune privilege and uveitis. Ocul Immunol Inflamm (2010) 0.81
Idiotypic expression of antibodies to retinal S-antigen in experimental autoimmune uveoretinitis. Immunology (1987) 0.81
Prevention of experimental autoimmune uveoretinitis and experimental autoimmune pinealitis in (Lewis x Brown-Norway) F1 rats by HgCl2 injections. Immunology (1991) 0.81
Regulation of experimental autoimmune uveitis in rats--separation of MHC and non-MHC gene effects. Clin Exp Immunol (1991) 0.80
Immunotherapeutic strategies in autoimmune uveitis. Autoimmun Rev (2014) 0.80
G-protein-coupled receptor kinases in inflammation and disease. Genes Immun (2015) 0.80
Anti-CD3 antibody ameliorates experimental autoimmune uveitis by inducing both IL-10 and TGF-β dependent regulatory T cells. Clin Immunol (2011) 0.79
The importance of specific IgG and IgE autoantibodies to retinal S antigen, total serum IgE, and sCD23 levels in autoimmune and infectious uveitis. J Clin Immunol (1999) 0.79
High incidence of antibodies to lens proteins in sera from patients with uveitis. Graefes Arch Clin Exp Ophthalmol (2006) 0.79
Resemblance between rhodopsin kinase and S-antigen induced uveitis. Br J Ophthalmol (1981) 0.79
S antigen specific effector T cell activation detected by cytokine flow cytometry. Br J Ophthalmol (2002) 0.79
Visual Cone Arrestin 4 Contributes to Visual Function and Cone Health. Invest Ophthalmol Vis Sci (2015) 0.79
Neuron-associated class III beta-tubulin isotype, retinal S-antigen, synaptophysin, and glial fibrillary acidic protein in human medulloblastomas: a clinicopathological analysis of 36 cases. Acta Neuropathol (1992) 0.79
IFN-β inhibits the increased expression of IL-9 during experimental autoimmune uveoretinitis. PLoS One (2012) 0.78
Self-association of arrestin family members. Handb Exp Pharmacol (2014) 0.78
A pathogenic autoimmune process targeted at a surrogate epitope. J Exp Med (1994) 0.78
Serum antibody level to S-antigen in children with chronic uveitis. Br J Ophthalmol (1985) 0.78
Antigenic cross-reactivity between human T lymphotropic virus type I (HTLV-I) and retinal antigens recognized by T cells. Clin Exp Immunol (1994) 0.77
The characterization of testicular cell (TC)-specific T-cell clones induced by intratesticular Listeria monocytogenes infection: TC-specific T cells with atypical cytokine profile transfer orchitis. Immunology (1997) 0.77
Isolation of retinal lymphocytes in experimental autoimmune uveoretinitis: phenotypic and functional characterization. Immunology (1993) 0.77
Upregulation of DR3 expression in CD4⁺ T cells promotes secretion of IL-17 in experimental autoimmune uveitis. Mol Vis (2011) 0.76
Apoptosis of CD4+ T cells occurs in experimental autoimmune anterior uveitis (EAAU). Clin Exp Immunol (1999) 0.76
The role of Th17-associated cytokines in the pathogenesis of experimental autoimmune uveitis (EAU). Cytokine (2015) 0.76
Antigenicity and uveitogenicity of partially purified peptides of a retinal autoantigen, S-antigen. Immunology (1987) 0.75
Expression Analysis of Cytokine and Chemokine Genes during the Natural Course of Murine Experimental Autoimmune Uveoretinitis. ISRN Inflamm (2012) 0.75
Arrestin 1 and Cone Arrestin 4 Have Unique Roles in Visual Function in an All-Cone Mouse Retina. Invest Ophthalmol Vis Sci (2015) 0.75
Trout red blood cell arrestin (TRCarr), a novel member of the arrestin family: cloning, immunoprecipitation and expression of recombinant TRCarr. Biochem J (1996) 0.75
The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity. Nature (1987) 3.85
Extreme retinal remodeling triggered by light damage: implications for age related macular degeneration. Mol Vis (2008) 1.77
Cellular immune responsiveness of uveitis patients to retinal S-antigen. Am J Ophthalmol (1980) 1.75
Treatment of intraocular inflammatory disease with cyclosporin A. Lancet (1983) 1.74
A dominant Stargardt's macular dystrophy locus maps to chromosome 13q34. Arch Ophthalmol (1994) 1.59
Vortex or whorl formation of cultured human corneal epithelial cells induced by magnetic fields. Eye (Lond) (1996) 1.54
A novel gene for autosomal dominant Stargardt-like macular dystrophy with homology to the SUR4 protein family. Invest Ophthalmol Vis Sci (2001) 1.48
Experimental allergic uveitis: homologous retina as uveitogenic antigen. Nature (1965) 1.47
Oral tolerance in experimental autoimmune uveoretinitis. Distinct mechanisms of resistance are induced by low dose vs high dose feeding protocols. J Immunol (1993) 1.47
Space-occupying orbital masses in children. A review of 250 consecutive biopsies. Ophthalmology (1986) 1.43
Cyclosporin a. Inhibition of experimental autoimmune uveitis in Lewis rats. J Clin Invest (1981) 1.40
S-antigen uveitis in primates. A new model for human disease. Arch Ophthalmol (1981) 1.39
Retinal ischemia and risk of neovascularization following central retinal vein obstruction. Ophthalmology (1982) 1.38
Identification of a major pathogenic epitope in the human IRBP molecule recognized by mice of the H-2r haplotype. Invest Ophthalmol Vis Sci (1995) 1.37
Induction of heme oxygenase 1 in the retina by intense visible light: suppression by the antioxidant dimethylthiourea. Proc Natl Acad Sci U S A (1995) 1.35
Pineal reactivity of anti-retina sera. Invest Ophthalmol Vis Sci (1977) 1.33
Management of posterior uveal melanoma. Surv Ophthalmol (1992) 1.29
Polypeptide variants of beta-arrestin and arrestin3. J Biol Chem (1993) 1.27
Primary and secondary structure of bovine retinal S antigen (48-kDa protein). Proc Natl Acad Sci U S A (1987) 1.25
Growth rates and doubling times of posterior uveal melanomas. Ophthalmology (1984) 1.20
Experimental allergic uveitis: clinicopathologic features associated with varying doses of S antigen. Arch Ophthalmol (1979) 1.11
S-antigen: preparation and characterization of site-specific monoclonal antibodies. Curr Eye Res (1990) 1.09
The protective effect of ascorbate in retinal light damage of rats. Invest Ophthalmol Vis Sci (1985) 1.06
Congenital retinal macrovessels. Arch Ophthalmol (1982) 1.05
Efficacy of panretinal photocoagulation in preventing neovascular glaucoma following ischemic central retinal vein obstruction. Ophthalmology (1982) 1.05
Ocular anomalies simulating double optic discs. Can J Ophthalmol (1981) 1.03
Comparison of hemolysin, hemolysin-destructive factor and hemodigestive enzyme production by strains of Vibrio cholerae and Vibrio cholerae type El Tor. Tex Rep Biol Med (1968) 1.01
S-antigen immunoreactivity in human pineal glands and pineal parenchymal tumors. A monoclonal antibody study. Acta Neuropathol (1986) 1.01
Peripheral rheumatoid ulceration and evidence for conjunctival collagenase production. Am J Ophthalmol (1979) 1.00
Molecular mimicry between a uveitopathogenic site of S-antigen and viral peptides. Induction of experimental autoimmune uveitis in Lewis rats. J Immunol (1990) 1.00
Mucosa specific lymphocytes in the human conjunctiva, corneoscleral limbus and lacrimal gland. Curr Eye Res (1994) 0.99
Identification of T cell recognition sites in S-antigen: dissociation of proliferative and pathogenic sites. Cell Immunol (1989) 0.99
Retinal S-antigen and retinoblastoma: a monoclonal antibody and flow cytometric study. Invest Ophthalmol Vis Sci (1985) 0.98
The rod outer segment phospholipid/opsin ratio of rats maintained in darkness or cyclic light. Invest Ophthalmol Vis Sci (1977) 0.98
Reaction of papain with -bromo- -(5-imidazolyl)propionic acid. Biochemistry (1972) 0.97
S-antigen in the developing retina and pineal gland: a monoclonal antibody study. Invest Ophthalmol Vis Sci (1985) 0.97
Experimental autoimmune uveitis: cellular immune responsiveness. Invest Ophthalmol Vis Sci (1980) 0.97
The ocular surface as part of the mucosal immune system: conjunctival mucosa-specific lymphocytes in ocular surface pathology. Eye (Lond) (1995) 0.97
Rhodopsin and retinoblastoma. A monoclonal antibody histopathologic study. Arch Ophthalmol (1986) 0.96
S-antigen: characterization of a pathogenic epitope which mediates experimental autoimmune uveitis and pinealitis in Lewis rats. Curr Eye Res (1987) 0.95
Familial uveal melanoma, III. Is the occurrence of familial uveal melanoma coincidental?. Arch Ophthalmol (1996) 0.95
Neuroblastic differentiation potential of the human retinoblastoma cell lines Y-79 and WERI-Rb1 maintained in an organ culture system. An immunohistochemical, electron microscopic, and biochemical study. Am J Pathol (1989) 0.94
A simple trimerization of 2,3-butanedione yielding a selective reagent for the modification of arginine in proteins. J Am Chem Soc (1968) 0.94
Choroidal neovascularization in an eye with a macular hole. Ann Ophthalmol (1989) 0.94
Fresh-frozen cucumber as a mount for conjunctival and corneal tissue in cryomicrotomy. Arch Ophthalmol (1994) 0.93
Rabbit ocular and pineal autoimmune response to retina antigens. Curr Eye Res (1986) 0.93
Scatter photocoagulation for choroidovitreal neovascularization. Retina (1984) 0.93
Flow cytometry of uveal melanomas. Cancer Biochem Biophys (1986) 0.93
Characterization of a new, potent, immunopathogenic epitope in S-antigen that elicits T cells expressing V beta 8 and V alpha 2-like genes. J Immunol (1991) 0.93
Amelioration of photic injury in rat retina by ascorbic acid: a histopathologic study. Invest Ophthalmol Vis Sci (1985) 0.93
Retinal S antigen and retinoblastoma. A monoclonal antibody histopathologic study. Arch Ophthalmol (1985) 0.93
Pineal gland involvement in retina-induced experimental allergic uveitis. Invest Ophthalmol Vis Sci (1978) 0.93
DNA-binding activity of retinoblastoma protein is intrinsic to its carboxyl-terminal region. Cell Growth Differ (1990) 0.92
Modification of arginine in proteins by oligomers of 2,3-butanedione. Biochemistry (1970) 0.92
Levels of mRNA encoding proteins of the cGMP cascade as a function of light environment. Exp Eye Res (1991) 0.92
Metastatic uveal melanoma: diffuse hepatic metastasis in a patient with concurrent normal serum liver enzyme levels and liver scan. Arch Ophthalmol (1985) 0.92
Malattia leventinese presenting with subretinal neovascular membrane and hemorrhage. Am J Ophthalmol (2001) 0.92
Association of leptospiral seroreactivity and breed with uveitis and blindness in horses: 372 cases (1986-1993). J Am Vet Med Assoc (1995) 0.92
Hereditary retinal dystrophy in the rat: rhodopsin, retinol, vitamin A deficiency. Exp Eye Res (1975) 0.91
Epitope mapping of bovine retinal S-antigen with monoclonal antibodies. Curr Eye Res (1988) 0.90
Adaptive changes in visual cell transduction protein levels: effect of light. Exp Eye Res (1991) 0.90
The role of two retina antigens in production of experimental allergic uveitis and its suppression by mycobacteria. Int Arch Allergy Appl Immunol (1971) 0.90
Identification of a potent new pathogenic site in human retinal S-antigen which induces experimental autoimmune uveoretinitis in LEW rats. Cell Immunol (1990) 0.90
Immunohistochemical characterization of human retinoblastomas in situ with multiple markers. Am J Ophthalmol (1987) 0.90
Inhibition of experimental autoimmune uveoretinitis by oral administration of S-antigen and synthetic peptides. Autoimmunity (1992) 0.90
Characteristics of two new retinoblastoma cell lines: WERI-Rb24 and WERI-Rb27. J Pediatr Ophthalmol Strabismus (1990) 0.89
Expression of multiple forms of clusterin during light-induced retinal degeneration. Curr Eye Res (2001) 0.89
Cytogenetic findings in primary uveal melanoma. Cancer Genet Cytogenet (1994) 0.89
Hepatic metastasis and orbital recurrence of uveal melanoma after 42 years. Am J Ophthalmol (1985) 0.89
S-antigen: identification of the MAbA9-C6 monoclonal antibody binding site and the uveitopathogenic sites. Curr Eye Res (1986) 0.89
Mass spectrometric analysis of rhodopsin from light damaged rats. Mol Vis (2000) 0.89
Effect of hydroxylamine on the subcellular distribution of arrestin (S-antigen) in rod photoreceptors. Vis Neurosci (1994) 0.89
Differential expression of mRNA and protein encoding retinal and pineal S-antigen during the light/dark cycle. J Neurochem (1990) 0.89
Endogenous ascorbate regenerates vitamin E in the retina directly and in combination with exogenous dihydrolipoic acid. Curr Eye Res (1995) 0.88
Changing concepts in the management of retinoblastoma. Ophthalmic Surg (1990) 0.88
Sequence homology between yeast histone H3 and uveitopathogenic site of S-antigen: lymphocyte cross-reaction and adoptive transfer of the disease. Cell Immunol (1989) 0.88
Rod cell-specific antigens in retinoblastoma. Arch Ophthalmol (1989) 0.88
An 18-mer peptide derived from the retinal S antigen induces uveitis and pinealitis in primates. Clin Exp Immunol (1989) 0.88
Inhibition of experimental autoimmune uveitis by retinal photoreceptor antigens coupled to spleen cells. Cell Immunol (1992) 0.88
Localization of a uveitogenic soluble retinal antigen in the normal guinea pig eye by an indirect fluorescent antibody technique. Int Arch Allergy Appl Immunol (1973) 0.87
Accuracy of clinical estimates of tumor dimensions. A clinical-pathologic correlation study of posterior uveal melanomas. Retina (1985) 0.87
An antimelanoma monoclonal antibody and the histopathology of uveal melanomas. Arch Ophthalmol (1985) 0.86
Genetic aspects of uveal melanoma: a brief review. Semin Oncol (1996) 0.86
Autosomal dominant Stargardt-like macular dystrophy: I. Clinical characterization, longitudinal follow-up, and evidence for a common ancestry in families linked to chromosome 6q14. Am J Ophthalmol (1999) 0.86
Modification of standard proteinase K/phenol method for DNA isolation to improve yield and purity from frozen blood. J Med Genet (1995) 0.86
The role of uveal and retinal antigens in experimental autoimmune ocular pathology. Mod Probl Ophthalmol (1976) 0.85
Identification of a uveitopathogenic and lymphocyte proliferation site in bovine S-antigen. Cell Immunol (1988) 0.85
Retinoblastoma-like phenotype expressed in medulloblastomas. J Neuropathol Exp Neurol (1995) 0.85
Transient, cyclic changes in mouse visual cell gene products during the light-dark cycle. J Neurosci Res (1992) 0.85
In vitro unresponsiveness to autologous sequences of the immunopathogenic autoantigen, S-antigen. J Immunol (1991) 0.85
Ultrastructural, histochemical, and biochemical studies of the melanin metabolism in eye and skin of pallid mice. J Invest Dermatol (1982) 0.84
Induction of experimental autoimmune uveitis by the retinal photoreceptor cell protein, phosducin. Curr Eye Res (1992) 0.84
Characterization of hemolysin and hemodigestive enzyme produced by strains of Vibrio cholerae and Vibrio cholerae type El Tor. Tex Rep Biol Med (1968) 0.83
Human retinal S-antigen. Isolation, purification, and characterization. Invest Ophthalmol Vis Sci (1984) 0.83
Autoimmune uveo-retinitis in the rat sensitized with retina photoreceptor cell antigen. Int Arch Allergy Appl Immunol (1973) 0.83